FHI 360

- Country
- 🇿🇲Zambia
- Ownership
- Private
- Established
- 1971-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fhi360.org
Clinical Trials
60
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (48 trials with phase data)• Click on a phase to view related trials
The CATALYST Study
- Conditions
- HIV Prevention
- First Posted Date
- 2023-07-10
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 6069
- Registration Number
- NCT05937698
- Locations
- 🇰🇪
Chulaimbo sub-country hospital, Kisumu, Kenya
🇰🇪Migosi Health, Kisumu, Kenya
🇰🇪Likoni Sub-country hospital, Mombasa, Kenya
Eswatini Ring Study: Increasing PrEP Options for Women
- Conditions
- HIV Prevention
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 904
- Registration Number
- NCT05889533
- Locations
- 🇸🇿
Dvokolwako Health Centre, Dvokolwako, Eswatini
🇸🇿Manzini KP Community Centre, Manzini, Eswatini
🇸🇿Matsapha Mobile Clinic, Matsapha, Eswatini
Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
- Conditions
- Anemia
- Interventions
- Drug: COCsDevice: LNG IUS
- First Posted Date
- 2022-02-10
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 600
- Registration Number
- NCT05233956
- Locations
- 🇰🇪
Kangemi Health Center, Nairobi, Kenya
Casea S Contraceptive Implants (Casea S) Trial
- Conditions
- Contraception
- Interventions
- Drug: 22.2 mg Etonogestrel (ENG)Drug: 44.4 mg Etonogestrel (ENG)
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 20
- Registration Number
- NCT05174884
- Locations
- 🇩🇴
Clinica Profamilia, Santo Domingo, DN, Dominican Republic
REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- FHI 360
- Target Recruit Count
- 767535
- Registration Number
- NCT05016895
- Locations
- 🇨🇮
FHI 360, Abidjan, Côte D'Ivoire
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
News
Daré Bioscience and Theramex Partner to Develop Novel Biodegradable Contraceptive Implant
Daré Bioscience and Theramex have entered into a co-development agreement for Casea S, a first-in-category biodegradable contraceptive implant designed to last 18-24 months.